Aesica appoints VP, Business Development and Business Development Director for Finished Dose

To drive service in Europe and achieve further growth

CDMO Aesica has appointed two people to senior business development positions.

Detlef Behrens has taken the role of Vice President, Business Development, Finished Dose, while Sven Wrabletz has joined the company as Business Development Director, Finished Dose.

Behrens has overall responsibility for business development and for finished dose services, covering formulation development, bulk manufacturing and packaging with a full international remit across the Group.

Wrabletz is also responsible for finished dose development, manufacturing and packaging but with a geographic remit covering Northern Germany, Benelux and Eastern Europe.

Both positions are based in Germany. Behrens reports directly to Ian Muir, Managing Director, Finished Dose. Prior to working for Aesica, he held senior business development roles at Piramal and NextPharma.

Wrabletz reports to Behrens and joined Aesica from packaging specialist Clondalkin.

You may also like

Manufacturing

Aesica to exhibit at CPhI Worldwide 2017

Aesica is a leading pharmaceutical contract development and manufacturing organisation for both API and finished dose forms
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How contract manufacturers can bridge the innovation–commercialisation divide

With R&D budgets under pressure, the pharmaceutical industry would do well to look to the contract manufacturing sector for innovative approaches and technologies that could make production more effective and efficient, and achieve more with finite resources
Manufacturing

Aesica Pharmaceuticals implements Ci-DMS Weigh and Dispense from CI Precision

Analysis demonstrated that the MES Weigh and Dispense and SAP Interface modules would mitigate the risk of human error
Manufacturing

Aesica adds development capability at Queenborough plant in Kent

Opens new purpose-built facility and expands services for highly potent and controlled drugs
Design & Build

Aesica relocates development and clinical manufacturing services from Nottingham to Queenborough, Kent

Offers double the capacity of the existing development centre
Manufacturing

Bespak and Aesica unveil new single source supply chain solution for drug delivery manufacturing services

Set to streamline and speed products to market while reducing cost and complexity of development
Manufacturing

LIVE FROM CPHI: Aesica introduces new supply chain service model

And outlines its plans for the future with sister company medical device manufacturer Bespak
Subscribe now